Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.902,29
2,80%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV ICO Therapeutics Inc (ICO) ICO Therapeutics Inc (ICO) Notizie

ICO

ICO Therapeutics (ICO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:ICO
DataOraFonteTitoloSimboloCompagnia
17/08/202123:30PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ICOTSXV:ICOICO Therapeutics Inc
17/08/202123:24PR Newswire (Canada)IIROC Trading Resumption - ICOTSXV:ICOICO Therapeutics Inc
22/03/202113:05PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ICOTSXV:ICOICO Therapeutics Inc
22/03/202113:03PR Newswire (Canada)IIROC Trading Halt - ICOTSXV:ICOICO Therapeutics Inc
25/05/201622:00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2016 Financial ResultsTSXV:ICOICO Therapeutics Inc
14/04/201622:00PR Newswire (Canada)iCo Therapeutics Announces Year End 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
17/02/201623:35PR Newswire (Canada)iCo Therapeutics Inc. Announces Grant of Stock Options and Recent CEO Share PurchasesTSXV:ICOICO Therapeutics Inc
18/01/201613:00PR Newswire (Canada)iCo Strategic ReorganizationTSXV:ICOICO Therapeutics Inc
24/12/201513:00PR Newswire (Canada)iCo Therapeutics Announces Changes to Board of DirectorsTSXV:ICOICO Therapeutics Inc
25/11/201501:21PR Newswire (Canada)/C O R R E C T I O N from Source -- iCo Therapeutics Inc./TSXV:ICOICO Therapeutics Inc
24/11/201523:00PR Newswire (Canada)iCo Therapeutics Announces Third Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/10/201513:00PR Newswire (Canada)iCo Therapeutics Announces Manufacturing Update for Oral Amp B ProgramTSXV:ICOICO Therapeutics Inc
26/08/201523:00PR Newswire (Canada)iCo Therapeutics Announces Second Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/06/201522:00PR Newswire (Canada)iCo Therapeutics Announces Voting & Election Results from Annual Meeting of ShareholdersTSXV:ICOICO Therapeutics Inc
28/05/201523:00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2015 Financial ResultsTSXV:ICOICO Therapeutics Inc
27/04/201523:00PR Newswire (Canada)iCo Therapeutics Announces Year End 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
17/04/201521:15PR Newswire (Canada)iCo Therapeutics Inc. Comments on Recent Market ActivityTSXV:ICOICO Therapeutics Inc
28/11/201423:00PR Newswire (Canada)iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate UpdateTSXV:ICOICO Therapeutics Inc
04/11/201413:00PR Newswire (Canada)iCo Therapeutics Announces Oral Amphotericin Presentations at AAPSTSXV:ICOICO Therapeutics Inc
22/10/201413:00PR Newswire (Canada)iCo Therapeutics Announces Advancement of Oral Amphotericin B ProgramTSXV:ICOICO Therapeutics Inc
29/08/201413:00PR Newswire (Canada)iCo Therapeutics Announces Second Quarter 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
19/08/201413:00PR Newswire (Canada)iCo Therapeutics Announces Positive Oral Amphotericin B Study ResultsTSXV:ICOICO Therapeutics Inc
15/07/201419:29PR Newswire (Canada)iCo Therapeutics Inc. - No Material ChangeTSXV:ICOICO Therapeutics Inc
30/06/201413:00PR Newswire (Canada)iCo Therapeutics Announces Director Election Results From Its Annual Meeting of ShareholdersTSXV:ICOICO Therapeutics Inc
09/06/201414:00PR Newswire (Canada)iCo Therapeutics Announces Top-Line Primary Endpoint Data from iCo-007 Phase 2 iDEAL Study in Diabetic Macular EdemaTSXV:ICOICO Therapeutics Inc
29/05/201423:00PR Newswire (Canada)iCo Therapeutics Announces First Quarter 2014 Financial ResultsTSXV:ICOICO Therapeutics Inc
29/04/201413:00PR Newswire (Canada)iCo Therapeutics Announces Poster Presentation at ARVOTSXV:ICOICO Therapeutics Inc
24/04/201423:00PR Newswire (Canada)iCo Therapeutics Announces Year End 2013 Financial ResultsTSXV:ICOICO Therapeutics Inc
26/03/201413:45Marketwired CanadaTrue Drinks Announces Scot Cohen as New DirectorTSXV:ICOICO Therapeutics Inc
05/03/201413:00PR Newswire (Canada)iCo Therapeutics Announces Final Eight Month Patient Visit in Phase 2 iDEAL StudyTSXV:ICOICO Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:ICO

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network